{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "inhibits_modification",
    "modifications" : [ {
      "modification_type" : "acetylation"
    } ],
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "be:NFkappaB",
      "entity_text" : "NF-kappaB",
      "entity_type" : "protein"
    },
    "is_direct" : false,
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00192",
      "entity_text" : "HDAC inhibitor",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "In primary neuronal cells, we have demonstrated that treatment with valproic acid, a Class I and II HDAC inhibitor, induces acetylation and activation of NF-kappaB, protecting cells from hypoxia induced apoptosis [XREF_BIBR].",
  "reading_complete" : "2020-07-28T11:30:45Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T11:27:28Z",
  "trigger" : "induces",
  "evidence" : [ "HDAC inhibitor, induces acetylation and activation of NF-kappaB" ],
  "pmc_id" : "4824319",
  "score" : 0
}